JP Morgan Chase’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.11M Sell
469,832
-33,733
-7% -$363K ﹤0.01% 3117
2026
Q1
$4.07M Sell
503,565
-86,000
-15% -$941K ﹤0.01% 3505
2025
Q4
$6.66M Sell
589,565
-745,890
-56% -$9.24M ﹤0.01% 3059
2025
Q3
$20M Sell
1,335,455
-1,236,587
-48% -$18M ﹤0.01% 2098
2025
Q2
$36.3M Buy
2,572,042
+612,209
+31% +$10.9M ﹤0.01% 1531
2025
Q1
$47.1M Sell
1,959,833
-19,336
-1% -$682K ﹤0.01% 1346
2024
Q4
$73.9M Buy
1,979,169
+1,169,721
+145% +$54.6M 0.01% 1095
2024
Q3
$40.4M Buy
809,448
+372,737
+85% +$14.5M ﹤0.01% 1465
2024
Q2
$15.2M Buy
436,711
+299,063
+217% +$11.8M ﹤0.01% 2094
2024
Q1
$7.53M Buy
137,648
+17,662
+15% +$875K ﹤0.01% 2743
2023
Q4
$5.14M Sell
119,986
-172,574
-59% -$5.37M ﹤0.01% 3062
2023
Q3
$7.61M Sell
292,560
-35,403
-11% -$736K ﹤0.01% 2508
2023
Q2
$7.84M Buy
327,963
+19,996
+6% +$344K ﹤0.01% 2496
2023
Q1
$4.21M Sell
307,967
-377,424
-55% -$6.01M ﹤0.01% 2973
2022
Q4
$9.51M Buy
+685,391
New +$9.68M ﹤0.01% 2306

Other funds holding BHVN

JP Morgan Chase's BHVN Position: Q2 2026 in Review

JP Morgan Chase reduced its Biohaven (BHVN) stake by 6.7% in Q2 2026, selling an estimated $363K and leaving 469,832 shares worth $7.11M. The position accounts for ﹤0.01% of the portfolio, ranked #3117.

JP Morgan Chase first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. The position peaked at $73.9M in Q4 2024. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • JP Morgan Chase held 469,832 shares of Biohaven worth $7.11M as of Q2 2026.
  • JP Morgan Chase sold 33,733 Biohaven shares in Q2 2026, an estimated $363K.
  • Biohaven made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3117 holding.
  • JP Morgan Chase first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
  • JP Morgan Chase's Biohaven position peaked at $73.9M in Q4 2024.
  • 292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.